Bravo's original scripted series "Imposters" is back for a second season on April 5th. The complicated show leaves viewers wondering what it's like to both date a con artist, and be a con artist. Rob Heaps plays Ezra Bloom in the popular Bravo show and he joins Cheddar to give a teaser on what to expect in the new season. Heaps says the second season starts with the need to get rid of a ring worth millions. Heaps says he laughed out loud when he first read the "Imposters" pilot. He found it to be both humorous and surprising. For Heaps, the exciting part of playing this character is the relatability. Everyone has fallen in love, everyone has been lied to, and everyone has felt cheated.

Share:
More In Culture
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
First-Time Homebuyers Face Rising Mortgage Rates
Buying a new home is tough right now; but for first-time buyers, it's an especially challenging time, with obstacles like rising mortgage rates and record-breaking home prices. The housing market is not expected to get much friendlier, as mortgage rates are expected to continue to climb as the Federal Reserve proceeds with its plans for rate hikes in an effort to stifle inflation. Jonathan Miller, President and CEO of real estate appraiser Miller Samuel, joins Cheddar News' Closing Bell to discuss.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Load More